Skip to main content

Table 2 Multivariate analysis for clinicopathological factors and pathological response after neoadjuvant chemotherapy in GC patients

From: Clinicopathological factors affecting the effect of neoadjuvant chemotherapy in patients with gastric cancer

Factors

Odds ratio (95 % CI)

P

1. Age (years)

 ≥ 60

1.840 (1.016–3.332)

0.044

 < 60

1

 

2. cT stage

 T2

1

 

 T3

0.592 (0.186–1.885)

0.375

 T4a

0.419 (0.135–1.294)

0.131

 T4b

0.197 (0.032–1.210)

0.079

3. Pathological type

 Well-differentiated or moderately differentiated

2.606 (1.321–5.140)

0.006

 Poorly differentiated or signet-ring cell

1

 

4. Weight loss

 No weight loss

2.110 (1.161–3.834)

0.014

 Weight loss

1

 
  1. GC gastric cancer, cT stage clinical T stage, CI confidence interval